29.43
+0.74
+(2.58%)
At close: April 17 at 4:00:00 PM EDT
29.43
0.00
(0.00%)
After hours: April 17 at 4:00:09 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | 23.48M | 25.18M | 105.1M | 111.2M |
| Low Estimate | 22.25M | 25M | 103M | 111.2M |
| High Estimate | 24.7M | 25.35M | 107.2M | 111.2M |
| Year Ago Sales | 18.54M | 20.16M | 86.67M | 105.1M |
| Sales Growth (year/est) | 26.64% | 24.88% | 21.26% | 5.80% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.07 | -0.21 | -0.62 | -0.12 |
| EPS Actual | -0.21 | -0.41 | -0.34 | -0.18 |
| Difference | -0.14 | -0.2 | 0.28 | -0.06 |
| Surprise % | -200.00% | -95.24% | 45.16% | -56.52% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SMTI | -- | -- | -- | -- |
| S&P 500 | 7.04% | 4.85% | 8.57% | 14.16% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/26/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/26/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/23/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/22/2025 |
| Initiated | HC Wainwright & Co.: Buy | 12/23/2024 |
Related Tickers
ADDV-B.ST ADDvise Group AB (publ)
1.4580
+10.45%
POCI Precision Optics Corporation, Inc.
3.9500
-1.25%
NEPH Nephros, Inc.
2.0000
+5.82%
INFU InfuSystem Holdings, Inc.
4.9100
-1.41%
NXGL NEXGEL, Inc.
2.8300
0.00%
MLSS Milestone Scientific Inc.
0.9025
-0.28%
STXS Stereotaxis, Inc.
1.8500
+3.35%
ALC Alcon Inc.
92.54
+0.53%
ALGN Align Technology, Inc.
171.41
+2.53%
ISRG Intuitive Surgical, Inc.
482.74
+0.29%